Historical essay - Enhanced Prospects for the future

被引：13

作者：

Gallo, RC ^{[1
]}

Montagnier, L

机构：

[1] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA

[2] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA

[3] World Fdn AIDS Res & Prevent, F-75015 Paris, France

来源：

SCIENCE | 2002年 / 298卷 / 5599期

关键词：

D O I：

10.1126/science.1079864

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1730 / 1731

页数：2

共 9 条

[1] Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes [J].

Barouch, DH ;

Kunstman, J ;

Kuroda, MJ ;

Schmitz, JE ;

Santra, S ;

Peyerl, FW ;

Krivulka, GR ;

Beaudry, K ;

Lifton, MA ;

Gorgone, DA ;

Montefiori, DC ;

Lewis, MG ;

Wolinsky, SM ;

Letvin, NL .

NATURE, 2002, 415 (6869) :335-339

[2]

Davis C, 2001, J HUMAN VIROL, V4, P113

[3] Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques [J].

Fouts, T ;

Godfrey, K ;

Bobb, K ;

Montefiori, D ;

Hanson, CV ;

Kalyanaraman, VS ;

DeVico, A ;

Pal, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11842-11847

[4] Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].

Guay, LA ;

Musoke, P ;

Fleming, T ;

Bagenda, D ;

Allen, M ;

Nakabiito, C ;

Sherman, J ;

Bakaki, P ;

Ducar, C ;

Deseyve, M ;

Emel, L ;

Mirochnick, M ;

Fowler, MG ;

Mofenson, L ;

Miotti, P ;

Dransfield, K ;

Bray, D ;

Mmiro, F ;

Jackson, JB .

LANCET, 1999, 354 (9181) :795-802

[5] Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol [J].

Heredia, A ;

Davis, C ;

Redfield, R .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) :246-255

[6]

Khanna KV, 2002, J CLIN INVEST, V109, P205

[7] HIV fusion and its inhibition [J].

LaBranche, CC ;

Galasso, G ;

Moore, JP ;

Bolognesi, DP ;

Hirsch, MS ;

Hammer, SM .

ANTIVIRAL RESEARCH, 2001, 50 (02) :95-115

[8] HIV-1 neutralizing antibodies: How full is the bottle? [J].

Moore, JP ;

Burton, DR .

NATURE MEDICINE, 1999, 5 (02) :142-144

[9] Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity [J].

Palani, A ;

Shapiro, S ;

Josien, H ;

Bara, T ;

Clader, JW ;

Greenlee, WJ ;

Cox, K ;

Strizki, JM ;

Baroudy, BM .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) :3143-3160

← 1 →